Bgp Laboratories Profile
Key Indicators
- Authorised Capital ₹ 70.00 Cr
as on 20-12-2024
- Paid Up Capital ₹ 65.00 Cr
as on 20-12-2024
- Company Age 5 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 1648.52%
(FY 2022)
- Profit -6.18%
(FY 2022)
- Ebitda -29.91%
(FY 2022)
- Net Worth 178.93%
(FY 2022)
- Total Assets 193.70%
(FY 2022)
About Bgp Laboratories
The Corporate was formerly known as Chitt Laboratories Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 70.00 Cr and a paid-up capital of Rs 65.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Bgp Laboratories Private Limited India is Parag Patel as COMPANY SECRETARY. Jayesh Patel and Geeta Patel serve as directors at the Company.
- CIN/LLPIN
U24230GJ2019PTC107864
- Company No.
107864
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Apr 2019
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Bgp Laboratories?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Parag Patel | Company Secretary | 01-Aug-2021 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jayesh Patel  | Director | 29-Apr-2019 | Current |
| Geeta Patel | Director | 29-Apr-2019 | Current |
Financial Performance of Bgp Laboratories.
Bgp Laboratories Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 1648.52% increase. The company also saw a slight decrease in profitability, with a 6.18% decrease in profit. The company's net worth Soared by an impressive increase of 178.93%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bgp Laboratories?
In 2022, Bgp Laboratories had a promoter holding of 100.00%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
B G P Healthcare Private LimitedActive 17 years 8 monthsJayesh Patel and Geeta Patel are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Bgp Laboratories?
Bgp Laboratories has a workforce of 13 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bgp Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bgp Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
